drugset / Trial / NCT03024086

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

NCT03024086

Phase 3 Completed 124 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.

Timeline

Start
2016-12-12
Primary completion
2017-04-25
Completion
2017-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject DWJ1252 Unknown
Comparator Mosapride Small molecule

Indications